Two puffs of 90 μg albuterol prior to 3% saline sputum induction results in less FEV-1 decline than single concentration 25 mg/ml methacholine challenge

John B. Hagan, Arvind Madaan, Chang Keun Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Assessment of sputum eosinophilia has shown benefit in the diagnosis and monitoring of asthma. However, the possibility of bronchospasm related to the hypertonic saline used in sputum induction appears to have limited this procedure's acceptance in clinical practice. Objective: Because the methacholine (MCH) challenge has been widely accepted as safe in the diagnosis of mild asthma, we sought to compare the safety of SI with 3% hypertonic saline following pretreatment with 2 puffs of 90 μg albuterol to that of a single concentration 25 mg/mL MCH challenge. Methods: We performed a retrospective review of 152 consecutive subjects, 57 with mild asthma and the remaining with other respiratory problems who had undergone both a SI and a MCH challenge at our single site tertiary care referral center. Results: Median reduction of FEV-1 in subjects with and without asthma (n = 152) was 9.95% in the MCH group compared to 35% in the SI group (p value < 0.0001). FEV-1 was reduced in excess of 20% in 33 of 152 (21.7%) MCH challenge tests compared to 1 of 152 (0.66%) SI. Median reduction of FEV-1 in asthmatic subjects (n = 57) was 17.86% in the MCH group compared to 32% in the SI group (p value <0.0001). Conclusions: With regard to potential bronchoconstriction, we conclude that 2 puffs of 90 μg albuterol administered prior to 3% saline sputum induction results in less FEV-1 decline than single concentration 25 mg/mL MCH.

Original languageEnglish (US)
Pages (from-to)397-401
Number of pages5
JournalAllergy and Asthma Proceedings
Volume27
Issue number5
DOIs
StatePublished - Sep 2006

Fingerprint

Methacholine Chloride
Albuterol
Sputum
Asthma
Tertiary Care Centers
Bronchial Spasm
Bronchoconstriction
Eosinophilia
Safety

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Two puffs of 90 μg albuterol prior to 3% saline sputum induction results in less FEV-1 decline than single concentration 25 mg/ml methacholine challenge. / Hagan, John B.; Madaan, Arvind; Kim, Chang Keun.

In: Allergy and Asthma Proceedings, Vol. 27, No. 5, 09.2006, p. 397-401.

Research output: Contribution to journalArticle

@article{38f84667e1d54730857b7a04be9d02c5,
title = "Two puffs of 90 μg albuterol prior to 3{\%} saline sputum induction results in less FEV-1 decline than single concentration 25 mg/ml methacholine challenge",
abstract = "Background: Assessment of sputum eosinophilia has shown benefit in the diagnosis and monitoring of asthma. However, the possibility of bronchospasm related to the hypertonic saline used in sputum induction appears to have limited this procedure's acceptance in clinical practice. Objective: Because the methacholine (MCH) challenge has been widely accepted as safe in the diagnosis of mild asthma, we sought to compare the safety of SI with 3{\%} hypertonic saline following pretreatment with 2 puffs of 90 μg albuterol to that of a single concentration 25 mg/mL MCH challenge. Methods: We performed a retrospective review of 152 consecutive subjects, 57 with mild asthma and the remaining with other respiratory problems who had undergone both a SI and a MCH challenge at our single site tertiary care referral center. Results: Median reduction of FEV-1 in subjects with and without asthma (n = 152) was 9.95{\%} in the MCH group compared to 35{\%} in the SI group (p value < 0.0001). FEV-1 was reduced in excess of 20{\%} in 33 of 152 (21.7{\%}) MCH challenge tests compared to 1 of 152 (0.66{\%}) SI. Median reduction of FEV-1 in asthmatic subjects (n = 57) was 17.86{\%} in the MCH group compared to 32{\%} in the SI group (p value <0.0001). Conclusions: With regard to potential bronchoconstriction, we conclude that 2 puffs of 90 μg albuterol administered prior to 3{\%} saline sputum induction results in less FEV-1 decline than single concentration 25 mg/mL MCH.",
author = "Hagan, {John B.} and Arvind Madaan and Kim, {Chang Keun}",
year = "2006",
month = "9",
doi = "10.2500/aap.2006.27.2900",
language = "English (US)",
volume = "27",
pages = "397--401",
journal = "Allergy and Asthma Proceedings",
issn = "1088-5412",
publisher = "OceanSide Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Two puffs of 90 μg albuterol prior to 3% saline sputum induction results in less FEV-1 decline than single concentration 25 mg/ml methacholine challenge

AU - Hagan, John B.

AU - Madaan, Arvind

AU - Kim, Chang Keun

PY - 2006/9

Y1 - 2006/9

N2 - Background: Assessment of sputum eosinophilia has shown benefit in the diagnosis and monitoring of asthma. However, the possibility of bronchospasm related to the hypertonic saline used in sputum induction appears to have limited this procedure's acceptance in clinical practice. Objective: Because the methacholine (MCH) challenge has been widely accepted as safe in the diagnosis of mild asthma, we sought to compare the safety of SI with 3% hypertonic saline following pretreatment with 2 puffs of 90 μg albuterol to that of a single concentration 25 mg/mL MCH challenge. Methods: We performed a retrospective review of 152 consecutive subjects, 57 with mild asthma and the remaining with other respiratory problems who had undergone both a SI and a MCH challenge at our single site tertiary care referral center. Results: Median reduction of FEV-1 in subjects with and without asthma (n = 152) was 9.95% in the MCH group compared to 35% in the SI group (p value < 0.0001). FEV-1 was reduced in excess of 20% in 33 of 152 (21.7%) MCH challenge tests compared to 1 of 152 (0.66%) SI. Median reduction of FEV-1 in asthmatic subjects (n = 57) was 17.86% in the MCH group compared to 32% in the SI group (p value <0.0001). Conclusions: With regard to potential bronchoconstriction, we conclude that 2 puffs of 90 μg albuterol administered prior to 3% saline sputum induction results in less FEV-1 decline than single concentration 25 mg/mL MCH.

AB - Background: Assessment of sputum eosinophilia has shown benefit in the diagnosis and monitoring of asthma. However, the possibility of bronchospasm related to the hypertonic saline used in sputum induction appears to have limited this procedure's acceptance in clinical practice. Objective: Because the methacholine (MCH) challenge has been widely accepted as safe in the diagnosis of mild asthma, we sought to compare the safety of SI with 3% hypertonic saline following pretreatment with 2 puffs of 90 μg albuterol to that of a single concentration 25 mg/mL MCH challenge. Methods: We performed a retrospective review of 152 consecutive subjects, 57 with mild asthma and the remaining with other respiratory problems who had undergone both a SI and a MCH challenge at our single site tertiary care referral center. Results: Median reduction of FEV-1 in subjects with and without asthma (n = 152) was 9.95% in the MCH group compared to 35% in the SI group (p value < 0.0001). FEV-1 was reduced in excess of 20% in 33 of 152 (21.7%) MCH challenge tests compared to 1 of 152 (0.66%) SI. Median reduction of FEV-1 in asthmatic subjects (n = 57) was 17.86% in the MCH group compared to 32% in the SI group (p value <0.0001). Conclusions: With regard to potential bronchoconstriction, we conclude that 2 puffs of 90 μg albuterol administered prior to 3% saline sputum induction results in less FEV-1 decline than single concentration 25 mg/mL MCH.

UR - http://www.scopus.com/inward/record.url?scp=33750372373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750372373&partnerID=8YFLogxK

U2 - 10.2500/aap.2006.27.2900

DO - 10.2500/aap.2006.27.2900

M3 - Article

C2 - 17063670

AN - SCOPUS:33750372373

VL - 27

SP - 397

EP - 401

JO - Allergy and Asthma Proceedings

JF - Allergy and Asthma Proceedings

SN - 1088-5412

IS - 5

ER -